The Lancet Conferences: HPV and Cancer 2010
Latest professional practice and future clinical management
Human papillomavirus (HPV) is purported to be the proximate cause of 10% of malignant diseases in women, and HPV-associated cancers account for 5% of the total global cancer burden. These include those of the cervix, vagina, vulva, anus, and oropharynx, and, more recently, those of the head and neck region. Although the link between HPV and cancer has been sufficiently proven, much uncertainty surrounds the effect of the new HPV vaccines on these cancers and the future clinical management of HPV-associated cancers.
This conference will provide an opportunity for regional and international leaders from the oncology community to address the growing public-health and daily practice issues associated with HPV and cancer.